| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1B | $5.7B | $5.6B | $5.5B | $4.6B | $0.8B | $0.8B | $0.7B |
| Cost of Revenue | $3.5B | $3.2B | $3.2B | $3.1B | $2.8B | $0.5B | $0.5B | $0.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.3B | $0.3B | — | — | — | — | — | — |
| SG&A Expense | $0.9B | $0.9B | $1.2B | $1.2B | $1.1B | $0.2B | $0.2B | $0.2B |
| Operating Income | $1.1B | $1.0B | $1.0B | $1.0B | $0.6B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.9B | $0.8B | $0.9B | $0.8B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $19.12 | $17.43 | $18.80 | $16.85 | $10.31 | $3.58 | $3.17 | $2.53 |
| EPS (Diluted) | $18.88 | $17.21 | $18.49 | $16.53 | $10.05 | $3.48 | $3.06 | $2.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.3B | $14.2B | $14.5B | $14.4B | $14.4B | $5.1B | $4.6B | $3.8B |
| Current Assets | $3.1B | $2.9B | $3.0B | $2.8B | $2.4B | $1.7B | $1.3B | $1.1B |
| Cash & Equivalents | $0.4B | $0.6B | $0.6B | $0.6B | $0.5B | $0.7B | $0.2B | $0.1B |
| Total Liabilities | $4.8B | $4.6B | $5.3B | $6.2B | $6.8B | $1.9B | $1.9B | $1.6B |
| Current Liabilities | $1.9B | $1.3B | $1.8B | $1.5B | $1.5B | $0.8B | $0.8B | $0.7B |
| Stockholders' Equity | $10.5B | $9.5B | $9.2B | $8.2B | $7.6B | $3.2B | $2.7B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.2B | $0.8B | $0.5B | $0.8B | $0.6B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.9B | $-0.2B | $-0.2B | $-0.2B | $-3.8B | $-0.1B | $-0.6B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.6B | $-0.9B | $-0.7B | $-0.1B | $2.8B | $-0.1B | $0.1B | $-0.3B |